Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1289715 | 0.75 | — | — | |
| SCHEMBL20511816 | 0.66 | PARP1 (0.46) | PARP1CA1CA2TSHR | |
| SCHEMBL20511815 | 0.66 | PARP1 (0.46) | PARP1CA1CA2TSHR | |
| SCHEMBL31586332 | 0.66 | TRPA1 (0.50) | PARP1CA1CA2TSHR | |
| SCHEMBL283346 | 0.66 | TRPA1 (0.50) | PARP1CA1CA2TSHR | |
| SCHEMBL3101821 | 0.65 | TRPA1 (0.41) | PARP1 | |
| SCHEMBL29539 | 0.65 | — | — | |
| SCHEMBL20528826 | 0.63 | TRPA1 (0.34) | PARP1TSHR | |
| SCHEMBL8343541 | 0.63 | TRPA1 (0.34) | PARP1TSHR | |
| Indene SCHEMBL8617 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1460 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3781162-A1 | EP4 INHIBITORS AND USE THEREOF | Arrys Therapeutics, Inc. (US) | 2021-02-24 | — | — | EP | claimed |
| CN-108290863-B | Substituted aminotriazoles useful as human chitinase inhibitors | 昂科艾伦迪治疗法公司 | 2020-05-05 | — | — | CN | claimed |
| WO-2019204257-A1 | EP4 INHIBITORS AND USE THEREOF | Arrys Therapeutics, Inc. (US) | 2019-10-24 | — | — | WO | claimed |
| EP-3177716-A1 | PEPTIDES USEFUL FOR TREATING CANCER | Warenius, Hilmar M (GB) | 2017-06-14 | — | — | EP | claimed |
| WO-2017049402-A1 | MULTI-FUNCTIONAL ANTI-MICROBIAL POLYMERS AND COMPOSITIONS CONTAINING SAME | GHANDI KHASHAYAR (CA) | 2017-03-30 | — | — | WO | claimed |
| WO-2016029146-A1 | SPECIFIC INHIBITORS OF METHIONYL-TRNA SYNTHETASE | UNIVERSITY OF WASHINGTON (US) | 2016-02-25 | — | — | WO | claimed |
| WO-2016020437-A1 | PEPTIDES USEFUL FOR TREATING CANCER | WARENIUS HILMAR M (GB) | 2016-02-11 | — | — | WO | claimed |
| EP-2935217-A1 | HISTONE DEMETHYLASE INHIBITORS | Quanticel Pharmaceuticals Inc (US) | 2015-10-28 | — | — | EP | claimed |
| WO-2014201544-A1 | ANTIMICROBIAL POLYMER INCORPORATING A QUATERNARY AMMONIUM GROUP | CHEMGREEN INNOVATION INC. (CA) | 2014-12-24 | — | — | WO | claimed |
| WO-2014100818-A1 | HISTONE DEMETHYLASE INHIBITORS | Quanticel Pharmaceuticals, Inc. (US) | 2014-06-26 | — | — | WO | claimed |
| EP-0931074-B1 | CONDENSED 4,5,6,7-TETRAHYDROBENZO C]THIOPHENES AS ENHANCER FOR CELL DIFFERENTIATION INDUCTION FACTOR ACTION | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-05-07 | — | — | EP | claimed |
| US-6451937-B1 | BY THERMALLY REACTING A FUNCTIONALIZING REAGENT AND THE HYDROCARBON IN THE PRESENCE OF A TRANSITION METAL COORDINATION CATALYST | SHELL OIL COMPANY | 2002-09-17 | — | — | US | claimed |
| WO-2002032900-A2 | ARYL OR HETEROARYL FUSED IMIDAZOLE COMPOUNDS AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS | PFIZER PHARMACEUTICALS INC. (JP) | 2002-04-25 | — | — | WO | claimed |
| CN-1076367-C | Blends of ultraviolet absorbers and polyesters | EASTMAN CHEM CO (US) | 2001-12-19 | — | — | CN | claimed |
| US-20010039349-A1 | Selective, Catalytic, thermal functionalization of secondary or aromatic C-H cyclic hydrocarbon bonds | SHELL OIL COMPANY | 2001-11-08 | — | — | US | claimed |
| CN-1250472-A | Photochemical superoxide generators | PROCTER & GAMBLE (US) | 2000-04-12 | — | — | CN | claimed |
| CN-1250471-A | Photochemical singlet oxygen generators having enhanced singlet oxygen yields | PROCTER & GAMBLE (US) | 2000-04-12 | — | — | CN | claimed |
| CN-1046273-C | 3-aryl-4-alkyl and 4,5-dialkyl-4H-1,2,4-triazoles useful as memory enhancers | MARRELL DOW PHARMACEUTICALS IN (US) | 1999-11-10 | — | — | CN | claimed |
| CN-1189176-A | Blends of UV absorbers and polyesters | EASTMAN CHEM CO (US) | 1998-07-29 | — | — | CN | claimed |
| CN-1134147-A | 3-aryl-4-alkyl and 4,5-dialkyl-4H-1,2,4-triazoles useful as memory enhancers | MERRELL DOW PHARMA (US) | 1996-10-23 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010039349-A1 | Selective, Catalytic, thermal functionalization of secondary or aromatic C-H cyclic hydrocarbon bonds | AHR, PAH, HRH3 | PARP1 1733/4885CA1 2185/4885CA2 2635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.